SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-213051
Filing Date
2020-08-07
Accepted
2020-08-07 17:25:39
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d85689ds3.htm S-3 431992
2 EX-1.2 d85689dex12.htm EX-1.2 203537
3 EX-4.3 d85689dex43.htm EX-4.3 298586
4 EX-4.5 d85689dex45.htm EX-4.5 119938
5 EX-4.6 d85689dex46.htm EX-4.6 117460
6 EX-4.7 d85689dex47.htm EX-4.7 97781
7 EX-5.1 d85689dex51.htm EX-5.1 30319
8 EX-23.1 d85689dex231.htm EX-23.1 1524
9 GRAPHIC g85689g0806142620593.jpg GRAPHIC 2533
10 GRAPHIC g85689g93w91.jpg GRAPHIC 65640
  Complete submission text file 0001193125-20-213051.txt   1396464
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-242372 | Film No.: 201085586
SIC: 2836 Biological Products, (No Diagnostic Substances)